🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,187 results for “Takeda” Clear

  1. TAK-279

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  2. TAK-279

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials

  3. TAK-279

    Takeda

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  4. TAK-329

    Takeda

    Type 1 Diabetes Mellitus

    phase 1 small molecule completed

    1 trial

  5. TAK-385

    Takeda

    Hormone Treatment-naïve Participants With Prostate Cancer

    phase 1 small molecule completed

    1 trial

  6. TAK-385 40 mg

    Takeda

    Japanese Premenopausal Healthy Adult Women

    phase 1 small molecule completed

    1 trial

  7. TAK-385 T2 Formulation

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  8. TAK-418

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  9. TAK-418

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    2 trials

  10. TAK-438

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  11. TAK-438

    Takeda

    Erosive Esophagitis(EE)

    phase 1 small molecule completed

    1 trial

  12. TAK-438

    Takeda

    Dose Finding Study

    phase 1 small molecule completed

    2 trials

  13. TAK-438

    Takeda

    Ascending Single Dose Study

    phase 1 small molecule completed

    1 trial

  14. TAK-438

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  15. TAK-438 OD

    Takeda

    Japanese Healthy Adult Male

    phase 1 small molecule completed

    1 trial

  16. TAK-438ASA

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  17. TAK-491

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  18. TAK-510

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  19. TAK-536

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  20. TAK-536

    Takeda

    Japanese Healthy Adult Male Participants

    phase 1 small molecule completed

    1 trial

  21. TAK-536 Tablet

    Takeda

    Japanese Healthy Adult Males

    phase 1 small molecule completed

    1 trial

  22. TAK-536TCH

    Takeda

    Hypertension

    phase 1 small molecule completed

    1 trial

  23. TAK-580

    Takeda

    Melanoma

    phase 1 small molecule terminated

    1 trial

  24. TAK-648

    Takeda

    Type 2 Diabetes Mellitus

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources